论文部分内容阅读
拉米夫定 (3 ＴＣ)是抗乙型肝炎病毒活性最强的抗病毒药之一 ,但临床实践证明 ,数周或数月的3 ＴＣ治疗只能缓解病情 ,大多数患者于停药后肝炎复发。为提高拉米夫定的疗效 ,本研究对比观察了拉米夫定联合胸腺肽与单用拉米夫定治疗慢性乙型肝炎 (ＣＨＢ)的疗效及不良反应 ,报?
Lamivudine (3 TC) is one of the most active antiviral drugs against hepatitis B virus, but clinical practice has proved that 3 TC treatment for weeks or months can only alleviate the condition, and most patients after stopping treatment Hepatitis recurrence. To improve the efficacy of lamivudine, this study compared the efficacy of lamivudine combined with thymosin and lamivudine alone in the treatment of chronic hepatitis B (CHB) efficacy and adverse reactions reported?